信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·11月2日亚宝药业(600351)龙虎榜数据:北向资金净卖出1565.13万元2023-11-2 21:24:27
·资源和能力互补 恩威医药重整信心药业迎来新进展2023-11-2 21:12:08
·以创新驱动高质量发展 深市生物医药公司前三季度实现营收8460亿元2023-11-2 21:06:14
·Ingenus贡献逾七成营收 联亚药业患大客户“依赖症”2023-11-2 20:33:57
·仙琚制药:地屈孕酮片药品注册申请获得受理2023-11-2 18:08:24
·恒瑞医药:截至10月31日累计回购股份14082323股2023-11-2 16:44:37
·上海医药:B019获得临床试验批准通知书2023-11-2 16:39:48
·11月2日赛隆药业涨停分析:医药概念热股2023-11-2 16:06:08
·*ST目药(600671)11月2日主力资金净卖出263.81万元2023-11-2 15:21:10
·诚达药业(301201)11月1日主力资金净卖出2766.65万元2023-11-2 15:01:18
·2023Q3持仓分析:医药持仓持续提升,CXO增持明显2023-11-2 11:14:59
·奥翔药业(603229)11月1日主力资金净卖出1292.71万元2023-11-2 8:43:25
·华领医药创始人、董事长、首席执行官陈力:药物开发回归科学本质 战略布局应关注核心忌盲目贪大2023-11-2 1:38:28
·鲁抗医药:注射用氨苄西林钠舒巴坦钠通过仿制药一致性评价2023-11-2 0:58:02
·11月1日誉衡药业(002437)龙虎榜数据:游资量化打板上榜2023-11-2 0:54:14
·九芝堂:子公司药品人骨髓间充质干细胞注射液于11月1日召开临床试验启动会2023-11-2 0:41:53
·津药药业:子公司药品通过仿制药质量和疗效一致性评价2023-11-2 0:32:19
·11月1日赛隆药业(002898)龙虎榜数据:游资量化打板上榜2023-11-2 0:15:22
·东亚药业:截止10月31日累计回购1,022,700股2023-11-1 23:06:25
·福瑞达重大资产出售顺利完成第二批次资产交割 聚焦发展医药、化妆品业务2023-11-1 22:23:31

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]